Newswise — Joslin Diabetes Center today announced that Enrique Caballero, M.D., director of Joslin's Latino Diabetes Initiative (LDI), has been named the 2009 recipient of the Bernardo Alberto Houssay Award. Given by the National Minority Quality Forum (NMQF), the award recognizes individuals who have contributed to the elimination of diabetes in minority communities.

As director of the LDI, Dr. Caballero works to improve the lives of Latinos who have or are at risk for developing diabetes. His research focuses on the impact of medical, psychological, socioeconomic and cultural factors on diabetes care among Latinos.

"Dr. Caballero's dedication to improving diabetes care and education for the Latino community is remarkable and the clinical research he and the LDI team are conducting into how diabetes impacts Latinos is yielding valuable information," said Ranch C. Kimball, President and CEO of Joslin. "I can think of no one more deserving of this honor than Dr. Caballero."

Dr. Caballero will be formally presented with the award today during the 6th Annual National Summit on Health Disparities in Washington, D.C.

"Helping those with the greatest needs is always the right cause," said Dr. Caballero. "It is an honor that our team has been recognized for the comprehensive work it does to develop socially and culturally oriented strategies to help the Latino population."

According to the NMQF, The Bernardo Alberto Houssay Award honors individuals who have made outstanding contributions to the elimination of diabetes in minority communities. Born in Argentina in 1887, Bernardo Alberto Houssay received the Nobel Prize in Medicine in 1947 for his discovery of the part played by the hormone of the anterior pituitary lobe in the metabolism of sugar.

As well as serving as the Director of the LDI, Dr. Caballero is a Clinical Investigator, Staff Endocrinologist and Director of Medical Affairs for Professional Education at Joslin. He is also an Assistant Professor of Medicine at Harvard Medical School. Dr. Caballero attained his degree from the National University of Mexico Medical School where he was awarded with the "Gabino Barreda" Medal for being the top student throughout the five-year program. He then completed his residency in Internal Medicine and a fellowship in Endocrinology at the National Institute of Nutrition in Mexico. In addition, he completed a fellowship in Endocrinology and Metabolism at the Lahey Clinic, Beth Israel Deaconess Medical Center and Joslin Diabetes Center and the program on Clinical Effectiveness at the Harvard School of Public Health.

About the Latino Diabetes Initiative (LDI)The Joslin LDI is a team of bilingual/bicultural providers, clinicians and administrative staff who provide socially and culturally appropriate state-of-the-art diabetes care and education, and who conduct clinical research, community outreach and provider education to improve health outcomes for Latinos living with diabetes and those at risk of developing the disease. Since its inception in 2002, there have been more than 4,433 patient visits to the bilingual Latino Clinic at Joslin in Boston, and the LDI has contributed to the development of some Joslin's continuing medical education programs, reaching thousands of providers throughout the country. For more information about the Joslin Latino Diabetes Initiative, call 617-264-2733 or visit www.joslin.org/latino.

About Joslin Diabetes CenterJoslin Diabetes Center is the world's preeminent diabetes research and clinical care organization. Joslin is dedicated to ensuring people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, call 1-800-JOSLIN-1 or visit www.joslin.org.